摘要
目的:探讨外周血中性粒细胞与淋巴细胞比值(NLR)及血小板与淋巴细胞比值(PLR)与新型冠状病毒肺炎(COVID-19)患者预后的相关性及其临床意义。方法回顾性分析了2020年1月24日—2020年4月25日确诊的183例COVID-19患者的临床资料及实验室检查结果,比较了重型与非重型患者的数据差异,并评估NLR、PLR等各项指标对患者住院时间的影响。结果入组患者中非重型患者143例,重型患者40例。重型患者入院时的CRP、白细胞计数、中性粒细胞计数、NLR、PLR均明显高于非重型患者,而淋巴细胞计数则明显低于非重型患者。单因素Cox回归分析显示年龄小于60岁患者住院时间较短(HR=0.583,95%CI:0.391~0.870;P=0.008);入院时淋巴细胞计数低(HR=4.129,95%CI:1.979~8.617;P<0.001)及NLR高(HR=1.601,95%CI:1.064~2.409;P<0.001)与COVID-19住院时间长、预后差相关。多因素Cox回归分析显示:入院时淋巴细胞计数(HR=6.004,95%CI:2.167~16.636;P=0.001)及NLR(HR=1.397,95%CI:1.092~1.853;P=0.037)是COVID-19住院时长的影响因素。结论NLR、PLR对COVID-19的病情严重程度具有一定的提示作用;NLR、淋巴细胞计数可能是COVID-19的重要预后预测指标,NLR越高、淋巴细胞计数越低,患者住院时间越长,对临床具有指导意义。
Objective To evaluate the predictive value and clinical significance of neutrophil-to-lymphocyte ratio(NLR)and platelet-to-lymphocyte ratio(PLR)in 2019-novel coronavirus disease.Methods The clinical characteristics and laboratory data of 183 COVID-19 cases diagnosed were retrospectively analyzed from January 24,2020 to April 25,2020,the clinical variations between severe and non-severe patients were compared,and the predictive value of NLR,PLR and other factors for length of hospitalization was evaluated.Results There were 40 severe cases and 143 non-severe cases involved in the study.CRP,WBC,NEU,NLR,PLR were significantly higher and LYM was lower in severe cases compared with non-severe cases.In univariate analysis,patients aged younger than 60 had shorter length of hospitalization(HR=0.583,95%CI:0.391-0.870,P=0.008),while lower LYM(HR=4.129,95%CI:1.979-8.617,P<0.001)and higher NLR(HR=1.601,95%CI:1.064-2.409,P<0.001)were associated with longer length of hospitalization.Multivariate analyses demonstrated that LYM(HR=6.004,95%CI:2.167-16.636,P=0.001)and NLR(HR=1.397,95%CI:1.092-1.853,P=0.037)were independent factors for predicating length of hospitalization.Conclusion NLR and PLR were closely related to the severity of COVID-19.Elevated NLR and lower LYM predicted long-term hospitalization,and they may be independent predictive factors for COVID-19.
作者
卢冰
陆益民
袁华
张燕
陈震
LU Bing;LU Yi-min;YUAN Hua;ZHANG Yan;CHEN Zhen(Department of Endocrinology,Affiliated Kunshan Hospital of Jiangsu University,Kunshan,Jiangsu,215300,China;Department of Intensive Care Unit,Optical Valley Branch of Tongji Hospital,Wuhan,Hubei,430030,China;Department of Respiratory and Critical Care Medicine,Affiliated Kunshan Hospital of Jiangsu University,Kunshan,Jiangsu,215300,China;Department of Intensive Care Unit,Affiliated Kunshan Hospital of Jiangsu University,Kunshan,Jiangsu,215300,China;Department of Respiratory and Critical Care Medicine,The First People's Hospital of Jiangxia District,Wuhan,Hubei,430200,China;Department of Oncology&Radiotherapy,Affiliated Kunshan Hospital of Jiangsu University,Kunshan,Jiangsu,215300,China;Department of Infectious Diseases,Huai'an No.4 People's Hospital,Huai'an,Jiangsu,223002,China)
出处
《中国血液流变学杂志》
CAS
2022年第1期67-71,共5页
Chinese Journal of Hemorheology
基金
昆山市第一人民医院新冠肺专项课题(XGF202009)。